Zhanlue Data Secures Tens of Millions in Series B+ Funding to Expand Intelligent Risk Control Footprint
Recently, fintech company Zhanlue Data announced that it had secured tens of millions of yuan in Series B+ financing. This round was led by Huazhi Capital, with participation from GF Qianhe Investment, and Shanjing Capital served as the exclusive financial advisor.
In recent years, as investment fervor has continued to surge in areas such as “healthcare insurance reform,” “innovative payment models,” and “regulatory technology,” a growing number of investment institutions have begun to focus on high-growth fintech companies with genuine differentiated competitiveness. Since its inception in 2016, Zhanlue Data has chosen the niche sector of the post-insurance healthcare market. Over the past five years, it has remained dedicated to serving healthcare payers and regulatory bodies through RPA+AI technologies, providing enterprise-level big data solutions to national and local social security, medical insurance, audit, and civil affairs departments, as well as to partners including commercial banks, insurance companies, insurance intermediaries, human resources firms, and pharmaceutical enterprises. It has now become an industry-leading provider of RPA+AI risk control technologies.
StackData was established in 2016 and secured angel-round financing from Banyan Capital, Fumu Asset Management, and Weicheng Fund. In mid-2017, it completed its Series A financing round, led by DCM Ventures and joined by Danhua Capital, Puhua Capital, 360 Finance, Banyan Capital, and Fumu Asset Management. In early 2019, it closed its Series B financing round with participation from Lingfeng Capital and FinVolution Group.
RPA (Robotic Process Automation) can automatically execute corresponding process tasks according to rules by using technologies that simulate human operations on computer interfaces, thereby replacing or assisting humans in completing related computer operations. The future of RPA + AI will bring about an unprecedented transformation for industries that still rely heavily on manual labor for repetitive, simple, and tedious transactional processes, and which involve massive data interactions.
Influenced by the macroeconomic backdrop, the global financial industry is currently facing numerous challenges. Meanwhile, as China’s financial system transitions toward high-quality development, it is also grappling with the difficulties of slowing growth and significant divergence. To adapt to the opportunities and challenges of this new landscape, and to achieve greater efficiency, risk reduction, cost savings, and improved user experience, an increasing number of financial enterprises are deploying RPA + AI technologies in their core business areas to build their core competitiveness.
Zhanlue Data enters the market through healthcare payment scenarios, integrating risk control models with expert expertise to build a closed-loop risk management solution for the financial and insurance industries using RPA+AI technology. This solution effectively coordinates across diverse business scenarios and develops tailored automated operations, anti-fraud, and anti-money laundering systems based on the unique characteristics of regulatory authorities, commercial insurers, commercial banks, and audit firms. It enables joint dynamic risk control throughout the entire product lifecycle, providing digital empowerment to partners.
To date, Zhanlüe Data has established close partnerships with over 100 industry partners, including China Life Insurance, PICC, China Taiping, China United Property Insurance, CPIC, AIA, CITIC-Prudential Life Insurance, China Continent Insurance, China Re Life Insurance, Qianhai Life Insurance, Hannover Re, Jiantai Insurance Brokers, Huatai Insurance Brokers, Huafu Insurance Brokers, CIIC Enterprise Services, Industrial and Commercial Bank of China, China Merchants Bank, BeiGene, and Merck & Co.
After years of rapid development, the fintech sector has begun to shift from single-node innovation toward empowering the digitalization of the entire insurance value chain. This transition has clearly injected momentum into the differentiated development of fintech companies and opened up greater possibilities. Through years of dedicated expertise in risk control, Zhanlue Data has established a solid and highly distinctive competitive advantage.
Zhanlue Data currently offers a suite of products, including an Intelligent Medical Insurance Claims Platform, an Intelligent Healthcare Security Risk Control Platform, an Intelligent Long-Term Care Management Platform, a Big Data Anti-Money Laundering (AML) Platform, an IFRS 17 System Platform, and a Financial Integrity System Platform. In addition to providing end-to-end automated services for claims reporting, adjustment, and risk control to commercial insurance companies, human resources firms, and insurance brokers, the company also delivers intelligent risk control, fund management, intelligent auditing, anti-money laundering, and integrity system construction services to social security administration agencies, audit institutions, banks, and other entities, thereby supporting evidence-based decision-making for policy formulation and adjustment.
“In recent years, health insurance has gradually become one of the fastest-growing segments in the industry, with the health insurance sector experiencing robust development. Zhanlue Data leverages artificial intelligence technology to deeply empower key processes such as claims cost control, reinsurance support, and insurance product design. Building on its modeling advantages accumulated from medical insurance operations, the company has identified commercial insurance monetization scenarios, refined its products through deep industry engagement, and established a strong portfolio of benchmark clients in both public medical insurance and commercial insurance sectors, thereby constructing significant competitive barriers within the industry.” Zheng Wenjie, Investment Director at Huazhi Capital, the lead investor in Zhanlue Data, stated, “We are optimistic about Zhanlue’s technological capabilities and team strength, and we look forward to the company creating greater industrial value in the ‘post-pandemic era.’”
Zhang Xuesi, Investment Director of TMT at GF Qianhe, stated: “The Chinese health insurance market holds immense potential for growth. We are pleased to see companies like Zhanlue Data empowering the industry’s intelligent information transformation and standardized development through foundational technological capabilities. By integrating claims cost control with product design to create a closed-loop business model and serving numerous benchmark clients, Zhanlue Data is well-positioned to contribute greater value to China’s insurtech sector in the future.”
Yang Yue, a partner at Shanjing Capital, shares this view: With the rapid development of the health insurance market, the importance of backend service capabilities for insurance products is growing day by day. Leveraging its unique risk control capabilities and data accumulation, Zhanlue Data continuously provides cost reduction and efficiency enhancement value to commercial insurance companies in product design, claims settlement, reinsurance, and other links. By empowering the industry’s information intelligence and reasonable standardization through underlying technical capabilities, it has established a firm foothold in the trillion-yuan after-market for insurance services, with promising prospects ahead.
Huazhi Capital is an investment firm focused on fintech, artificial intelligence, and big data. Led by Mr. Wan Jianhua, founder of China UnionPay and former Chairman of Guotai Junan Securities, the team comprises renowned industry experts who provide comprehensive oversight of industry trends and growth prospects to inform fund investment decisions, while also aggregating high-quality resources to support portfolio companies.
GF Qianhe Investment serves as GF Securities’ platform for investing in private companies using its own capital. It maintains a strategic focus on advanced manufacturing, semiconductors, healthcare, new consumption, and TMT, pursuing deep-sector deployment to co-shape corporate growth through “capital alignment, shared vision, and intellectual synergy.”
Shanjing Capital is an emerging financial advisory (FA) firm, with its team hailing from boutique investment banks and investment institutions. Shanjing Capital focuses on serving and investing in projects within the TMT sector, including consumer goods, industrial internet, AI, and other fields, covering stages from Series A to Series D. Notable clients include Huisuanzhang, Tongcheng Life, Tanji, Zhanlue Data, and Bolium Intelligence.